Back to User profile » Dr Jia Fan
Papers published by Dr Jia Fan:
Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study
Sun HC, Huang ZY, Wen T, Liu L, Zhu XD, Zhang E, Li C, Zhang X, Wang J, Fan J, Zhou J
Journal of Hepatocellular Carcinoma 2025, 12:1043-1056
Published Date: 22 May 2025
Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma
Zhou C, Yang ZF, Sun BY, Yi Y, Wang Z, Zhou J, Fan J, Gan W, Ren N, Qiu SJ
Journal of Hepatocellular Carcinoma 2023, 10:697-712
Published Date: 24 April 2023
Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
Tian MX, Luo LP, Liu WR, Deng W, Yin JC, Jin L, Jiang XF, Zhou YF, Qu WF, Tang Z, Wang H, Tao CY, Fang Y, Qiu SJ, Zhou J, Liu JF, Fan J, Shi YH
Cancer Management and Research 2019, 11:5187-5195
Published Date: 5 June 2019
Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child–Pugh I who underwent curative resection: a prognostic nomogram study [Erratum]
Gan W, Zhang MX, Wang JX, Fu YP, Huang JL, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ
Cancer Management and Research 2018, 10:6015-6016
Published Date: 20 November 2018
Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child–Pugh I who underwent curative resection: a prognostic nomogram study
Gan W, Zhang MX, Wang JX, Fu YP, Huang JL, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ
Cancer Management and Research 2018, 10:5383-5394
Published Date: 5 November 2018